Corbus Pharmaceuticals
CRBP
#10362
Rank
A$64.13 M
Marketcap
A$3.11
Share price
-15.40%
Change (1 day)
-83.26%
Change (1 year)

Earnings for Corbus Pharmaceuticals (CRBP)

Earnings in 2026 (TTM): -A$0.16 Billion

According to Corbus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.13 Billion a decrease over its 2024 earnings that were of -A$57.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corbus Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.16 Billion22.65%
2025 -A$0.13 Billion116.04%
2024 -A$57.92 Million-14.54%
2023 -A$67.78 Million28.56%
2022 -A$52.72 Million-37.68%
2021 -A$84.59 Million-54.41%
2020 -A$0.19 Billion59.28%
2019 -A$0.12 Billion35.87%
2018 -A$85.74 Million74.27%
2017 -A$49.2 Million62.94%
2016 -A$30.2 Million125.82%
2015 -A$13.38 Million251.68%
2014 -A$3.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Viking Therapeutics
VKTX
-A$0.95 Billion 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 70.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
-A$0.28 Billion 75.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$51.41 Million-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA